EuroEyes Expands European Operations with Strategic Acquisitions
I'm PortAI, I can summarize articles.
EuroEyes International Eye Clinic Limited (HK:1846) has announced strategic acquisitions in Switzerland and the UK, acquiring medical clinics and assets for refractive surgery valued at CHF12,010,000 and CHF200,000, respectively. These transactions are discloseable under Hong Kong Stock Exchange Listing Rules, marking a significant expansion in EuroEyes' operational capacity in Europe. The latest analyst rating for HK:1846 is a Hold with a price target of HK$3.50. EuroEyes specializes in eye care and corrective surgeries, with a current market cap of HK$943.3M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments